Lobbying Filing Details

Total Spending

$300,000

Activities

1

Lobbyists

1

Gov't Entities

5

Filing Information
Filing UUID:
4379e377-0ee4-40b1-8981-cb5acafcc5df
Type:
Q3 - 3rd Quarter - Report
Period:
2022 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 20, 2022 at 4:38 PM
Income:
$0
Expenses:
$300,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Frank Purcell
Registrant
INDIVIOR INC

pharmaceutical addiction treatment

Richmond, Virginia
Client
INDIVIOR INC
Virginia, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

HR955/S285, Medicaid Reentry Act, HR1384/S445 Mainstreaming Addiction Treatment Act; HR2067 Medication Access and Training Expansion Act; S5000 CARA 2.0 Act, FY2022 and FY2023 Labor-HHS-Education and Commerce-Justice-Science Appropriations; HR5376 Build Back Better Act re substance use disorder and mental health treatment; HR 7666, Restoring Hope for Mental Health and Well-being Act of 2022; HR 7667, FDA User Fee Amendments of 2022; S 4348, FDASLA Act of 2022; HR 7666, Restoring Hope for Mental Health and Well-being Act of 2022; HR 7667, FDA User Fee Amendments of 2022; S 4348, FDASLA Act of 2022

Lobbyists (1)
  • MR. FRANK J. PURCELL
Government Entities (5)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Office of Natl Drug Control Policy (NDCP)
  • Centers For Medicare and Medicaid Services (CMS)
  • Substance Abuse & Mental Health Services Administration (SAMHSA)

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.